|
|
|
Volumn 27, Issue 3 SUPPL. 5, 2000, Pages 15-21
|
|
Graft engineering
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 HYDROPEROXYCYCLOPHOSPHAMIDE;
ALDEHYDE DEHYDROGENASE;
ANTIBODY;
ANTIINFECTIVE AGENT;
CD34 ANTIGEN;
CD4 ANTIGEN;
CD56 ANTIGEN;
CD8 ANTIGEN;
CORTICOSTEROID;
CYCLOSPORIN;
CYTOKINE;
HLA ANTIGEN;
INTERLEUKIN 2;
METHOTREXATE;
MONOCLONAL ANTIBODY;
PENTOSTATIN;
APLASIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
ENGINEERING;
GRAFT VERSUS HOST REACTION;
HEALTH CARE COST;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
NATURAL KILLER CELL;
NONHUMAN;
PRIORITY JOURNAL;
REMISSION;
T LYMPHOCYTE;
ACUTE DISEASE;
ANTI-INFECTIVE AGENTS;
BONE MARROW PURGING;
CHRONIC DISEASE;
CLINICAL PROTOCOLS;
GRAFT VS HOST DISEASE;
HEMATOLOGIC NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HISTOCOMPATIBILITY;
HLA ANTIGENS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LYMPHOCYTE DEPLETION;
QUALITY OF LIFE;
T-LYMPHOCYTES;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION IMMUNOLOGY;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
|
EID: 0033916535
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (22)
|
